{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T13:41:22Z","timestamp":1788270082500,"version":"build-2803163510"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,19]],"date-time":"2016-05-19T00:00:00Z","timestamp":1463616000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.ejca.2016.04.010","type":"journal-article","created":{"date-parts":[[2016,5,30]],"date-time":"2016-05-30T22:30:47Z","timestamp":1464647447000},"page":"11-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"special_numbering":"C","title":["Second St. Gallen European Organisation for Research and Treatment of Cancer Gastrointestinal Cancer Conference: consensus recommendations on controversial issues in the primary treatment of rectal cancer"],"prefix":"10.1016","volume":"63","author":[{"given":"Manfred P.","family":"Lutz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Zalcberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob","family":"Glynne-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theo","family":"Ruers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Ducreux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Aust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Bujko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Evrard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Folprecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Gerard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelita","family":"Habr-Gama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Haustermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torbj\u00f6rn","family":"Holm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koert F.","family":"Kuhlmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Lordick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Mentha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Moehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris D.","family":"Nagtegaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Pigazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Pucciarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harm","family":"Rutten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Joachim","family":"Schmoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halfdan","family":"Sorbye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Van Cutsem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Weitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Otto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 6","key":"10.1016\/j.ejca.2016.04.010_bib1","doi-asserted-by":"crossref","first-page":"vi81","DOI":"10.1093\/annonc\/mdt240","article-title":"Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Glimelius","year":"2013","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.ejca.2016.04.010_bib2","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1093\/annonc\/mds236","article-title":"ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making","volume":"23","author":"Schmoll","year":"2012","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2016.04.010_bib3","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/SLA.0000000000000928","article-title":"Failure of evidence-based cancer care in the United States: the association between rectal cancer treatment, cancer center volume, and geography","volume":"260","author":"Monson","year":"2014","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.ejca.2016.04.010_bib4","doi-asserted-by":"crossref","first-page":"719","DOI":"10.6004\/jnccn.2015.0087","article-title":"Rectal cancer, version 2.2015","volume":"13","author":"Benson","year":"2015","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.ejca.2016.04.010_bib5","series-title":"Recent results in cancer research","doi-asserted-by":"crossref","first-page":"VIII","DOI":"10.1007\/978-3-319-08060-4","article-title":"Early gastrointestinal cancers II: rectal cancer","author":"Otto","year":"2014"},{"issue":"2","key":"10.1016\/j.ejca.2016.04.010_bib6","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1148\/radiol.2272011747","article-title":"Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison","volume":"227","author":"Brown","year":"2003","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.ejca.2016.04.010_bib7","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ijrobp.2013.06.2052","article-title":"MRI predictive factors for tumor response in rectal cancer following neoadjuvant chemoradiation therapy\u2013implications for induction chemotherapy?","volume":"87","author":"Yu","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.ejca.2016.04.010_bib8","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1148\/radiol.2323031368","article-title":"Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging\u2013a meta-analysis","volume":"232","author":"Bipat","year":"2004","journal-title":"Radiology"},{"issue":"12","key":"10.1016\/j.ejca.2016.04.010_bib9","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1002\/bjs.7662","article-title":"Relevance of magnetic resonance imaging-detected pelvic sidewall lymph node involvement in rectal cancer","volume":"98","author":"Group","year":"2011","journal-title":"Br J Surg"},{"issue":"10","key":"10.1016\/j.ejca.2016.04.010_bib10","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1007\/s10350-007-9019-0","article-title":"Limitations of early rectal cancer nodal staging may explain failure after local excision","volume":"50","author":"Landmann","year":"2007","journal-title":"Dis Colon Rectum"},{"issue":"2","key":"10.1016\/j.ejca.2016.04.010_bib11","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/BF00590909","article-title":"Number and size of lymph nodes and node metastases in rectal carcinomas","volume":"3","author":"Dworak","year":"1989","journal-title":"Surg Endosc"},{"issue":"3","key":"10.1016\/j.ejca.2016.04.010_bib12","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.crad.2003.10.001","article-title":"Local radiological staging of rectal cancer","volume":"59","author":"Brown","year":"2004","journal-title":"Clin Radiol"},{"issue":"1","key":"10.1016\/j.ejca.2016.04.010_bib13","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejrad.2003.12.005","article-title":"High-resolution MR imaging for nodal staging in rectal cancer: are there any criteria in addition to the size?","volume":"52","author":"Kim","year":"2004","journal-title":"Eur J Radiol"},{"issue":"7572","key":"10.1016\/j.ejca.2016.04.010_bib14","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1136\/bmj.38937.646400.55","article-title":"Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study","volume":"333","author":"Group MS","year":"2006","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.ejca.2016.04.010_bib15","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/bjs.7458","article-title":"One millimetre is the safe cut-off for magnetic resonance imaging prediction of surgical margin status in rectal cancer","volume":"98","author":"Taylor","year":"2011","journal-title":"Br J Surg"},{"issue":"2","key":"10.1016\/j.ejca.2016.04.010_bib16","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/bjs.5917","article-title":"Prognostic significance of magnetic resonance imaging-detected extramural vascular invasion in rectal cancer","volume":"95","author":"Smith","year":"2008","journal-title":"Br J Surg"},{"issue":"12","key":"10.1016\/j.ejca.2016.04.010_bib17","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/bjs.5525","article-title":"Late adverse effects of short-course preoperative radiotherapy in rectal cancer","volume":"93","author":"Pollack","year":"2006","journal-title":"Br J Surg"},{"issue":"11","key":"10.1016\/j.ejca.2016.04.010_bib18","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.clon.2015.06.010","article-title":"Prevention and Management of Radiation-induced Late Gastrointestinal Toxicity","volume":"27","author":"Teo","year":"2015","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"10","key":"10.1016\/j.ejca.2016.04.010_bib19","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/bjs.5506","article-title":"Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer","volume":"93","author":"Bujko","year":"2006","journal-title":"Br J Surg"},{"issue":"25","key":"10.1016\/j.ejca.2016.04.010_bib20","doi-asserted-by":"crossref","first-page":"6126","DOI":"10.1200\/JCO.2005.02.543","article-title":"Occurrence of second cancers in patients treated with radiotherapy for rectal cancer","volume":"23","author":"Birgisson","year":"2005","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.ejca.2016.04.010_bib21","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1470-2045(11)70097-3","article-title":"Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial","volume":"12","author":"van Gijn","year":"2011","journal-title":"Lancet Oncol"},{"issue":"22","key":"10.1016\/j.ejca.2016.04.010_bib22","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1200\/JCO.2007.15.3858","article-title":"Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer","volume":"26","author":"Braendengen","year":"2008","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2016.04.010_bib23","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/01.sla.0000257358.56863.ce","article-title":"The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma","volume":"246","author":"Peeters","year":"2007","journal-title":"Ann Surg"},{"issue":"9666","key":"10.1016\/j.ejca.2016.04.010_bib24","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0140-6736(09)60484-0","article-title":"Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial","volume":"373","author":"Sebag-Montefiore","year":"2009","journal-title":"Lancet"},{"issue":"17","key":"10.1016\/j.ejca.2016.04.010_bib25","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJMoa040694","article-title":"Preoperative versus postoperative chemoradiotherapy for rectal cancer","volume":"351","author":"Sauer","year":"2004","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.ejca.2016.04.010_bib26","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa060829","article-title":"Chemotherapy with preoperative radiotherapy in rectal cancer","volume":"355","author":"Bosset","year":"2006","journal-title":"N Engl J Med"},{"issue":"28","key":"10.1016\/j.ejca.2016.04.010_bib27","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.1200\/JCO.2006.06.7629","article-title":"Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203","volume":"24","author":"Gerard","year":"2006","journal-title":"J Clin Oncol"},{"issue":"31","key":"10.1016\/j.ejca.2016.04.010_bib28","doi-asserted-by":"crossref","first-page":"5124","DOI":"10.1200\/JCO.2009.22.0467","article-title":"Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03","volume":"27","author":"Roh","year":"2009","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2016.04.010_bib29","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ejso.2005.10.008","article-title":"Surgical treatment of primary locally advanced rectal cancer in Norway","volume":"32","author":"Eriksen","year":"2006","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2016.04.010_bib30","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/SLA.0b013e31820b8d52","article-title":"Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter, European study","volume":"253","author":"Taylor","year":"2011","journal-title":"Ann Surg"},{"issue":"14","key":"10.1016\/j.ejca.2016.04.010_bib31","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1002\/cncr.25866","article-title":"Preoperative chemoradiation may not always be needed for patients with T3 and T2N+ rectal cancer","volume":"117","author":"Frasson","year":"2011","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2016.04.010_bib32","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/bjs.7739","article-title":"Outcomes following surgery without radiotherapy for rectal cancer","volume":"99","author":"Mathis","year":"2012","journal-title":"Br J Surg"},{"issue":"6","key":"10.1016\/j.ejca.2016.04.010_bib33","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/DCR.0000000000000349","article-title":"Selective approach for upper rectal cancer treatment: total mesorectal excision and preoperative chemoradiation are seldom necessary","volume":"58","author":"Marinello","year":"2015","journal-title":"Dis Colon Rectum"},{"issue":"3","key":"10.1016\/j.ejca.2016.04.010_bib34","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.ijrobp.2008.01.063","article-title":"Local recurrence in rectal cancer: anatomic localization and effect on radiation target","volume":"72","author":"Syk","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"10.1016\/j.ejca.2016.04.010_bib35","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/bjs.9225","article-title":"Extent and completeness of mesorectal excision evaluated by postoperative magnetic resonance imaging","volume":"100","author":"Bondeven","year":"2013","journal-title":"Br J Surg"},{"issue":"1","key":"10.1016\/j.ejca.2016.04.010_bib36","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10151-008-0396-8","article-title":"Distribution of lymph nodes in the mesorectum: how deep is TME necessary?","volume":"12","author":"Perez","year":"2008","journal-title":"Tech Coloproctol"},{"issue":"9666","key":"10.1016\/j.ejca.2016.04.010_bib37","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0140-6736(09)60485-2","article-title":"Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial","volume":"373","author":"Quirke","year":"2009","journal-title":"Lancet"},{"issue":"25","key":"10.1016\/j.ejca.2016.04.010_bib38","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2005.14.779","article-title":"Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients\u2013a Dutch colorectal cancer group study","volume":"23","author":"Peeters","year":"2005","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.ejca.2016.04.010_bib39","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1002\/bjs.5819","article-title":"Risk factors for faecal incontinence after rectal cancer treatment","volume":"94","author":"Lange","year":"2007","journal-title":"Br J Surg"},{"issue":"3","key":"10.1016\/j.ejca.2016.04.010_bib40","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.ijrobp.2008.08.054","article-title":"Sacral insufficiency fractures after preoperative chemoradiation for rectal cancer: incidence, risk factors, and clinical course","volume":"74","author":"Herman","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"10.1016\/j.ejca.2016.04.010_bib41","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/bjs.9811","article-title":"Tumour regression in the randomized Stockholm III trial of radiotherapy regimens for rectal cancer","volume":"102","author":"Pettersson","year":"2015","journal-title":"Br J Surg"},{"issue":"31","key":"10.1016\/j.ejca.2016.04.010_bib42","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1200\/JCO.2012.42.9597","article-title":"Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04","volume":"30","author":"Ngan","year":"2012","journal-title":"J Clin Oncol"},{"issue":"16","key":"10.1016\/j.ejca.2016.04.010_bib43","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1200\/JCO.2011.40.1836","article-title":"Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO\/ARO\/AIO-94 randomized phase III trial after a median follow-up of 11 years","volume":"30","author":"Sauer","year":"2012","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2016.04.010_bib44","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/SLA.0000000000001193","article-title":"Prospective validation of a low rectal cancer magnetic resonance imaging staging system and development of a local recurrence risk stratification model: The MERCURY II study","volume":"263","author":"Battersby","year":"2016","journal-title":"Ann Surg"},{"issue":"24","key":"10.1016\/j.ejca.2016.04.010_bib45","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.1200\/JCO.2005.08.144","article-title":"Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate","volume":"23","author":"Folkesson","year":"2005","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.ejca.2016.04.010_bib46","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1056\/NEJMoa010580","article-title":"Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer","volume":"345","author":"Kapiteijn","year":"2001","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.ejca.2016.04.010_bib47","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1002\/1097-0142(19950501)75:9<2269::AID-CNCR2820750913>3.0.CO;2-I","article-title":"The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma. A prospective randomized trial. Stockholm Colorectal Cancer Study Group","volume":"75","author":"Cedermark","year":"1995","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.ejca.2016.04.010_bib48","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1200\/JCO.2001.19.7.1976","article-title":"No downstaging after short-term preoperative radiotherapy in rectal cancer patients","volume":"19","author":"Marijnen","year":"2001","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2016.04.010_bib49","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1463-1318.2011.02815.x","article-title":"Initial results of a randomized controlled trial comparing clinical and pathological downstaging of rectal cancer after preoperative short-course radiotherapy or long-term chemoradiotherapy, both with delayed surgery","volume":"14","author":"Latkauskas","year":"2012","journal-title":"Colorectal Dis"},{"issue":"4","key":"10.1016\/j.ejca.2016.04.010_bib50","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3109\/0284186X.2014.993768","article-title":"Review on adjuvant chemotherapy for rectal cancer why do treatment guidelines differ so much?","volume":"54","author":"Poulsen","year":"2015","journal-title":"Acta Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2016.04.010_bib51","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1470-2045(13)70599-0","article-title":"Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study","volume":"15","author":"Bosset","year":"2014","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.ejca.2016.04.010_bib52","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1093\/annonc\/mdu147","article-title":"Chronicle: results of a randomised phase III trial in locally advanced rectal cancer after neoadjuvant chemoradiation randomising postoperative adjuvant capecitabine plus oxaliplatin (XELOX) versus control","volume":"25","author":"Glynne-Jones","year":"2014","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2016.04.010_bib53","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/annonc\/mdu560","article-title":"Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial","volume":"26","author":"Breugom","year":"2015","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2016.04.010_bib54","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.radonc.2014.10.006","article-title":"No benefit of adjuvant Fluorouracil Leucovorin chemotherapy after neoadjuvant chemoradiotherapy in locally advanced cancer of the rectum (LARC): long term results of a randomized trial (I-CNR-RT)","volume":"113","author":"Sainato","year":"2014","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2016.04.010_bib55","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S1470-2045(14)71199-4","article-title":"Adjuvant chemotherapy after preoperative (chemo)radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data","volume":"16","author":"Breugom","year":"2015","journal-title":"Lancet Oncol"},{"issue":"11","key":"10.1016\/j.ejca.2016.04.010_bib56","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S1470-2045(14)70377-8","article-title":"Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial","volume":"15","author":"Hong","year":"2014","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2016.04.010_bib57","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.ijrobp.2013.12.012","article-title":"Local recurrence after complete clinical response and watch and wait in rectal cancer after neoadjuvant chemoradiation: impact of salvage therapy on local disease control","volume":"88","author":"Habr-Gama","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.ejca.2016.04.010_bib58","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ejso.2011.12.013","article-title":"Incidence of synchronous liver metastases in patients with colorectal cancer in relationship to clinico-pathologic characteristics. Results of a German prospective multicentre observational study","volume":"38","author":"Mantke","year":"2012","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejca.2016.04.010_bib59","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1477-7819-7-28","article-title":"Outcomes of resection and non-resection strategies in management of patients with advanced colorectal cancer","volume":"7","author":"Evans","year":"2009","journal-title":"World J Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejca.2016.04.010_bib60","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00384-008-0456-6","article-title":"Survival and symptomatic benefit from palliative primary tumor resection in patients with metastatic colorectal cancer: a review","volume":"23","author":"Eisenberger","year":"2008","journal-title":"Int J Colorectal Dis"},{"issue":"2","key":"10.1016\/j.ejca.2016.04.010_bib61","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3109\/0284186X.2013.837582","article-title":"Palliative pelvic radiotherapy of symptomatic incurable rectal cancer a systematic review","volume":"53","author":"Cameron","year":"2014","journal-title":"Acta Oncol"},{"issue":"11","key":"10.1016\/j.ejca.2016.04.010_bib62","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1093\/annonc\/mdt363","article-title":"Palliative radiotherapy and chemotherapy instead of surgery in symptomatic rectal cancer with synchronous unresectable metastases: a phase II study","volume":"24","author":"Tyc-Szczepaniak","year":"2013","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2016.04.010_bib63","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.amjsurg.2011.11.013","article-title":"Palliative management for patients with subacute obstruction and stage IV unresectable rectosigmoid cancer: colostomy versus endoscopic stenting: final results of a prospective randomized trial","volume":"204","author":"Fiori","year":"2012","journal-title":"Am J Surg"},{"issue":"8","key":"10.1016\/j.ejca.2016.04.010_bib64","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/archsurg.143.8.743","article-title":"Patterns of recurrence following liver resection for colorectal metastases: effect of primary rectal tumor site","volume":"143","author":"Assumpcao","year":"2008","journal-title":"Arch Surg"},{"issue":"4","key":"10.1016\/j.ejca.2016.04.010_bib65","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/bjs.7796","article-title":"Preoperative short-course radiotherapy with delayed surgery in primary rectal cancer","volume":"99","author":"Pettersson","year":"2012","journal-title":"Br J Surg"},{"issue":"7","key":"10.1016\/j.ejca.2016.04.010_bib66","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1093\/annonc\/mdt124","article-title":"Evaluation of short-course radiotherapy followed by neoadjuvant bevacizumab, capecitabine, and oxaliplatin and subsequent radical surgical treatment in primary stage IV rectal cancer","volume":"24","author":"van Dijk","year":"2013","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2016.04.010_bib67","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.radonc.2013.03.001","article-title":"Neoadjuvant treatment for unresectable rectal cancer: an interim analysis of a multicentre randomized study","volume":"107","author":"Bujko","year":"2013","journal-title":"Radiother Oncol"},{"issue":"6","key":"10.1016\/j.ejca.2016.04.010_bib68","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/codi.12879","article-title":"Pathological response of locally advanced rectal cancer to preoperative chemotherapy without pelvic irradiation","volume":"17","author":"Bensignor","year":"2015","journal-title":"Colorectal Dis"},{"issue":"3","key":"10.1016\/j.ejca.2016.04.010_bib69","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/DCR.0b013e3182411a8f","article-title":"Is an elective diverting colostomy warranted in patients with an endoscopically obstructing rectal cancer before neoadjuvant chemotherapy?","volume":"55","author":"Patel","year":"2012","journal-title":"Dis Colon Rectum"},{"issue":"4","key":"10.1016\/j.ejca.2016.04.010_bib70","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1001\/jamasurg.2013.1216","article-title":"The liver-first approach to the management of colorectal cancer with synchronous hepatic metastases: a systematic review","volume":"148","author":"Jegatheeswaran","year":"2013","journal-title":"JAMA Surg"},{"issue":"3","key":"10.1016\/j.ejca.2016.04.010_bib71","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/DCR.0b013e318279b743","article-title":"Long-term results of the \u201cliver first\u201d approach in patients with locally advanced rectal cancer and synchronous liver metastases","volume":"56","author":"Ayez","year":"2013","journal-title":"Dis Colon Rectum"},{"issue":"9","key":"10.1016\/j.ejca.2016.04.010_bib72","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S1470-2045(10)70172-8","article-title":"Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data","volume":"11","author":"Maas","year":"2010","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.ejca.2016.04.010_bib73","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.amjsurg.2014.09.024","article-title":"Simultaneous resection for rectal cancer with synchronous liver metastasis is a safe procedure","volume":"209","author":"Silberhumer","year":"2015","journal-title":"Am J Surg"},{"issue":"7","key":"10.1016\/j.ejca.2016.04.010_bib74","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1245\/s10434-011-2210-5","article-title":"Diagnostic accuracy of MRI for assessment of T category, lymph node metastases, and circumferential resection margin involvement in patients with rectal cancer: a systematic review and meta-analysis","volume":"19","author":"Al-Sukhni","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2016.04.010_bib75","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1245\/s10434-008-0231-5","article-title":"How good is endoscopic ultrasound in differentiating various T stages of rectal cancer? Meta-analysis and systematic review","volume":"16","author":"Puli","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejca.2016.04.010_bib76","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.2214\/AJR.08.1004","article-title":"A systematic approach to the interpretation of preoperative staging MRI for\u00a0rectal cancer","volume":"191","author":"Taylor","year":"2008","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"10.1016\/j.ejca.2016.04.010_bib77","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00423-011-0890-8","article-title":"Randomized clinical trial on preoperative radiotherapy 25 Gy in rectal cancer\u2013treatment results at 5-year follow-up","volume":"397","author":"Pach","year":"2012","journal-title":"Langenbecks Arch Surg"}],"updated-by":[{"DOI":"10.1016\/j.ejca.2016.08.017","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000}}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804916320780?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804916320780?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T06:04:51Z","timestamp":1600668291000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804916320780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":77,"alternative-id":["S0959804916320780"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2016.04.010","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.ejca.2016.08.017","asserted-by":"object"}]},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Second St. Gallen European Organisation for Research and Treatment of Cancer Gastrointestinal Cancer Conference: consensus recommendations on controversial issues in the primary treatment of rectal cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2016.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}